24th annual SCANDINAVIAN MEETING on Parkinson’s Disease and Related Disorders
“From Diagnosis to Management of Parkinson’s disease”
Clarion Malmö Live 17-18 April 2026, Malmö, Sweden
Update on the Gut and Microbiota in PD
Filip Scheperjans (Finland)
Depression in PD
Per Svenningsson (Sweden)
Physical activity and fall prevention: Value in PD
Bastian Bloem (Netherlands)
AbbVie symposium: Foslevodopa/foscarbidopa RWE – latest update and real world experience
Per Odin (Sweden), Per Svenningsson (Sweden)
Nordic Infucare symposium: LECIG; Evidence and Innovation to Improve Patient Outcomes in Advanced Parkinson’s Disease
Alan Whone (England)
Pump-based therapies for PD – state of the art
Tove Henriksen (Denmark)
The role of FUS in Parkinson’s disease and other neurodegenerations: Potentialities and Limitation
Raúl Martinez-Fernández (Spain)
Cognitive impairment and dementia in PD and the relationship to DLB
Dag Aarsland (Norway and UK)
Restless Legs – update
Birgit Högl (Austria)
Best experimental papers in last 12 months
Anders Björklund (Sweden)
Best clinical papers in last 12 months
Andrew Lees (UK)
Pain in PD
K Ray Chaudhuri (UK)
Disorders of Motivation: Impulse Control Disorders and Apathy
Dan Weintraub (US)
Consequences of preoperative magnetic resonance imaging in deep brain stimulation
Thomas Freiman (Germany)
Stemcell-based dopamine replacement for Parkinson’s disease- ”an update”
Gesine Paul-Visse (Sweden)
The role of imaging for understanding disease progression
Per Borghammer (Denmark)
Platform trials to assess disease modification therapies in PD
Olivier Rascol (France)
Pro/cons-talk: Is PET/SPECT imaging necessary for PD diagnosis?
Pro: Anne-Mette Løkkegaard (Denmark)
Con: Bastian Bloem (Netherlands)
Treatment strategies in early PD
Angelo Antonini (Italy)
Dystonia: Diagnosis, Pathophysiology and Treatment
Marie Vidailhet (France)
Ataxias – update
Bart van de Warrenburg (Netherlands)